Layoffs

Discussion in 'Pfizer' started by anonymous, Jun 30, 2020 at 1:35 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Let’s be realistic....they can’t pay us to stay home forever. When are the layoffs coming? Company could easily get rid of 75% of sales force. Most of them are lazy assholes who stayed home before the pandemic. Haha
     

  2. anonymous

    anonymous Guest

    HQ is currently conducting analytical review given for 5 months sales actually went up with virtual business model.
    Need base analysis show 1 virtual rep can cover 3 territories or 3 reps jobs.
    They can make 5x the phone calls to docs a day physical calls- (not VCC but phone calls & Zoom calls).
    In essence Strategy & Analytics have determine 1 rep can do the workload of 3 territories so how many reps in those territories.

    Now HQ (w McKinsey) is doing a needs assessment to identity which physicians, offices, geographies would perfer a virtual phone call or VCC vs a live in person rep.
    The results (due Q4), will determine how many reps are expendable & the cost savings globally.
    As 1 RD told me, this covid virus created an accidental 5 month Pilot to measure impact & sales in a virtual model to compare with normal business in 2019.
    (Hint- the results are not weighing in the "in person live rep" favor with those non technical products like Womens Health, Cluster 2, Derm, & Xeljanz)
     
  3. anonymous

    anonymous Guest

    With CEO being 100% evaluated & measured by BOD & shareholders with Stock performance, Albert is on very thin ice & maybe 1 more yr as the stock is at a 5 year low in 31s last wk. Down -35% from the 46 when he took over.

    So look for some massive change in the organization structure to jump start & decrease expenses for increase net profit so stock will get back to average wall street estimate of 50 a share ... massive layoffs will increase profits and the accidental pos results of the virtual business model might be the exact thing he needs to buy himself another year (every extra year for Albert is about $15 million)
    YES major changes coming in our structure & headcount
     
  4. anonymous

    anonymous Guest

    With CEO being 100% evaluated & measured by BOD & shareholders with Stock performance, Albert is on very thin ice & maybe 1 more yr as the stock is at a 5 year low in 31s last wk. Down -35% from the 46 when he took over.

    So look for some massive change in the organization structure to jump start & decrease expenses for increase net profit so stock will get back to average wall street estimate of 50 a share ... massive layoffs will increase profits and the accidental pos results of the virtual business model might be the exact thing he needs to buy himself another year (every extra year for Albert is about $15 million)
    YES major changes coming in our structure & headcount
     
  5. anonymous

    anonymous Guest

    Yep because damn Cluster 1 & 3 are top medical minds
     
  6. anonymous

    anonymous Guest

    Your brain is a non technical product.
     
  7. anonymous

    anonymous Guest

    guarantee he is a Cluster 1 /3 rep that thinks Cologuard is a technical sell.
     
  8. anonymous

    anonymous Guest

    LOL Cologuard is loss looser after overhead.
    Going direct to consumer model & spinning off to Mylan 2021.
    Eliquis only has few yrs LOE left but Tozninab got new patent w IM injection 2.5m usage so LOE is 2035. Lilly invested 1.8 Billion to Pfizer for additional co marketing rights upon approval.
    Bottom line only 2-3 products to promote in IM, and virtual sales model can cover same customers with 1/4th the reps.
     
  9. anonymous

    anonymous Guest

     
  10. anonymous

    anonymous Guest

    I believe you! No way we can continue with present structure. COVID has changed everything!
     
  11. anonymous

    anonymous Guest

    No changes until 2021. Al needs to get new structure in place and 1-2 quarters of financials, then hammer will drop as the restructure will produce a more significant increase in EPS based on the new smaller PFE financials.
     
  12. anonymous

    anonymous Guest

    So layoffs in sales force? Announced in 2020? In effect 1/1/2021?
     
  13. anonymous

    anonymous Guest

    Restructuring charges are taken in the quarter in which they are initiated, therefore I do not think he will see restructuring till 2021, this will impact the new Pfizer financials in a much more significant way.
     
  14. anonymous

    anonymous Guest

    With Covid ramping up in many states, no way hospitals and offices will allow reps in. Even states doing ok,with Covid will be saying NO to reps. Guaranteed layoffs in 2021
     
  15. anonymous

    anonymous Guest

    You work for Albert?
     
  16. anonymous

    anonymous Guest

    No layoffs until vaccine read outs. Lay-offs prior would indicate a vaccine failure or no confidence outcome.Stock would tank. It’s not for workers, it’s for leadership. We’re just along for the ride
     
  17. anonymous

    anonymous Guest

    Layoff were planned prior to COVID.
     
  18. anonymous

    anonymous Guest

    "Its coming"
     
  19. anonymous

    anonymous Guest

    Original poster stating layoffs were planned prior to Covid......enlighten us, how do you know that?
     
  20. anonymous

    anonymous Guest

    he knows it because this is cafepharma where everything in Pharma sucks and layoffs are always planned.